FLGT
insider transactionsFulgent Genetics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-6.0K
0 buy · 6.0K sell
Net value · 90d
-$106.3K
$0 in · $106.3K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
4
0 buy · 6.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Jian Xie KEY
President and COO
$38.4K
2.1K sh · $17.89
Own -1%
-
Sell·S
Chief Scientific Officer
$30.2K
1.7K sh · $17.89
Own -0%
-
Other·F
Ming Hsieh KEY
Chief Executive Officer
$79.5K
4.4K sh · $18.09
Own -0%
-
Other·F
Paul Kim KEY
CFO and Treasurer
$37.8K
2.1K sh · $18.09
Own -1%
-
Sell·S
Jian Xie KEY
President and COO
$21.1K
1.2K sh · $17.60
Own -0%
-
Sell·S
Chief Scientific Officer
$16.6K
945 sh · $17.60
Own -0%
-
Other·F
Ming Hsieh KEY
Chief Executive Officer
$52.1K
2.9K sh · $17.67
Own -0%
-
Other·F
Paul Kim KEY
CFO and Treasurer
$20.6K
1.2K sh · $17.67
Own -0%
-
Grant·A
Director
$0
8.4K sh
Own New
-
Grant·A
Director
$0
5.6K sh
Own +29%
-
Grant·A
Director
$0
11.1K sh
Own +65%
-
Grant·A
Director
$0
11.1K sh
Own +40%
-
Other·F
Chief Scientific Officer
$26.8K
1.6K sh · $16.31
Own -0%
-
Other·F
Jian Xie KEY
President and COO
$71.1K
4.4K sh · $16.31
Own -1%
-
Other·F
Paul Kim KEY
CFO and Treasurer
$44.8K
2.7K sh · $16.31
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 2, 2026 | Jian Xie KEY | Sell S | 2.1K | $38.4K |
| Jun 2, 2026 | Hanlin Gao | Sell S | 1.7K | $30.2K |
| Jun 1, 2026 | Ming Hsieh KEY | Other F | 4.4K | $79.5K |
| Jun 1, 2026 | Paul Kim KEY | Other F | 2.1K | $37.8K |
| May 27, 2026 | Jian Xie KEY | Sell S | 1.2K | $21.1K |
| May 27, 2026 | Hanlin Gao | Sell S | 945 | $16.6K |
| May 26, 2026 | Ming Hsieh KEY | Other F | 2.9K | $52.1K |
| May 26, 2026 | Paul Kim KEY | Other F | 1.2K | $20.6K |
| May 14, 2026 | Michael Nohaile | Grant A | 8.4K | $0 |
| May 14, 2026 | Michael Nohaile | Grant A | 5.6K | $0 |
| May 14, 2026 | Regina E Groves | Grant A | 11.1K | $0 |
| May 14, 2026 | Linda Dong | Grant A | 11.1K | $0 |
| Apr 26, 2026 | Hanlin Gao | Other F | 1.6K | $26.8K |
| Apr 26, 2026 | Jian Xie KEY | Other F | 4.4K | $71.1K |
| Apr 26, 2026 | Paul Kim KEY | Other F | 2.7K | $44.8K |
About FLGT insider trading
This page tracks insider transactions for Fulgent Genetics, Inc. (FLGT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.